Acciones correctivas implementadas frente a los problemas de medicamentos en Colombia (2015–2025): una revisión documental.

Abstract

Abstract To ensure the reliability of the information, a review of 50 sources was conducted, including scientific and academic articles as well as documents from current INVIMA and Ministry of Health regulations. The objective was to analyze the corrective actions adopted in Colombia in response to medication-related issues between 2015 and 2025. The findings show that, during this period, the medication supply problem stemmed primarily from the financial crisis of the EPS and pharmaceutical managers. Although the Colombian government has implemented regulations, reporting mechanisms, and sanctions, these corrective measures have not fully ensured stable access to medicines. System underfunding and the limited operational capacity of the EPS have reduced the effectiveness of these actions, maintaining barriers and delays in medication delivery. Consequently, without addressing the underlying financial issues or strengthening the responsibilities of EPS and pharmaceutical managers, it will not be possible to guarantee timely and effective access to essential medicines. Keywords: medicines - shortage – pharmacovigilance - risk - public policy – INVIMA - ministry of Health - National Superintendency of Health (supersalud) – Eps.